The main goal of this research was to evaluate the reduction activity of a novel Nitrobenzazolo[3,2-a]quinolinium (NBQ48) compound under hypoxic environment thru the formation of a fluorescent metabolite and further to evaluate the activity of the cytochrome P450 (CYP450) reducatase in the reduction of these compounds. To evaluate the reduction of NBQ48 and the formation of its fluorescent metabolite two (2) tumor cell lines in culture Toledo (lymphoma) and A431 (endothelial) where treated under nitrogen or argon saturated environments to create a hypoxic (low oxygen) environment. In a 15 ml conical tube 4×106 cells in RPMI 1640 media were treated with NBQ 48 (3mM) for a final volume of 5mL and incubated with argon or nitrogen saturated environment at 37ºC, 5%. Cells were exposed at different time periods (0 to 48 hours) to evaluate the effect of exposure time in the reduction of the NBQ48 by detecting the reduced fluorescent product, the amino-substituted ABQ48. In addition NBQ48 treated tumor cells were located inside a hypoxic chamber to evaluate the formation of the fluorescent metabolites indicative of a metabolically active cell. To determine if the CYP450 reductase enzyme is activated in the reduction of the NBQ towards the formation of the ABQ metabolite, an experiment containing the NBQs and the CYP reductases was designed. Four (4) samples were prepared: blank media hypoxic, NBQ experimental hypoxic, positive ABQ spiked and negative aerobic control NBQ. Samples with NBQ48 (0.4mM) were incubated for 24 hours. After the incubation period, fluorescence emissions indicating the reductive fluorescent product were measured using a Modulus fluorometer (blue filter). The results on tumor cells treated with NBQ48 under hypoxic conditions demonstrated reduction and the formation of a fluorescent product, amino-substituted ABQ48. The time dependent increase in fluorescence in comparison with non treated cells indicated that the reduction of the NBQ increased with time. Results on the determination of the activity of CYP450 in the reduction of the NBQ48 indicated that only samples containing the CYP450 showed the formation of a fluorescent species presumably, ABQ48. This study provides evidence of the reduction of NBQ48 and the formation of a fluorescent metabolite thru the activations of the CYP450 reductases. The implemented experimental design could also be used to determine activity of hypoxic tissues with clinical applications. Citation Format: Beatriz Zayas, Vivian Lebron, Juan P. Rivera, Christian Velez, Osvaldo Cox. Hypoxic bio-reduction of novel NBQ48 in treated tumor cells and the activity of cytochrome P450 reductase. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4774.
The main purpose of this research was to evaluate the effects of two novel benzazolo[3,2-a]quinolinium salts (ABQ-48 and NBQ48) on lymphoma cells (TOLEDO). The cationic nature of these BQS can facilitate its interaction with cell organelles such as mitochondria and DNA. To determine its potential cytotoxic effects the compounds were screened through the NCI 60 cell line protocol which determines the cell viability inhibitory activity in various cancer histological types. The IC50 dose for these compounds was determined and used to assess their apoptosis induction capacity evaluating apoptosis hallmark events such as DNA Fragmentation, Caspase 3&7 activators and mitochondrial membrane permeabilization. Additionally cell reduction potential of the compounds was measured. Results from the NCI 60 cell line protocol demonstrated the toxicity of BQS in multiple cancer types including breast and colon cancer cells. Preliminary results indicated mitochondrial membrane permeabilization on cells treated with NBQ48 (51.3%) and ABQ48 (57.67%) comparable to the positive controls camptothecin (51.6%) and valinomycin (55.3%). Treated cells also presented DNA fragmentation with NBQ48 and ABQ48 (28%) comparable to the positive control 37%. Preliminary data for caspases 3&7 activation strongly suggest an intrinsic apoptosis pathway. Analysis of the reduction of nitro substituted compound NBQ 48 to the amino substituted ABQ 48 on treated cells was determined by measuring an increment on fluorescence emission, characteristic of an amino specie. In conclusion, the study provides evidence of the induction of key apoptotic events as part of the mechanism of action of these novel BQS. Citation Format: Karoline Rios-Rodriguez, Jessica Soto, Christian Velez, Osvaldo Cox, Juan P. Rivera, Beatriz Zayas. Toxicity screening, apoptosis hallmark events and nitro reduction of novel quinolinium salts (BQS) on lymphoma cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1586. doi:10.1158/1538-7445.AM2014-1586
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.